메뉴 건너뛰기
Lancet
Volumn 357, Issue 9268, 2001, Pages 1544-1545
Lotronex and the FDA: A fatal erosion of integrity
Author keywords

[No Author keywords available]
Indexed keywords

ALOSETRON;
EID: 0035912536     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04776-0     Document Type: Note
Times cited : (67)
References (5)
  • 1
    • 0034712539 scopus 로고    scopus 로고
    • Efficacy and safety of alosetron in women with irritable bowel syndrome
    • M Camilleri AR Northcutt S Kong GE Dukes D McSorley AW Mangel Efficacy and safety of alosetron in women with irritable bowel syndrome Lancet 355 2000 1035 1040
    • (2000) Lancet , vol.355 , pp. 1035-1040
    • Camilleri, M1    Northcutt, AR2    Kong, S3    Dukes, GE4    McSorley, D5    Mangel, AW6
  • 2
    • 0035057423 scopus 로고    scopus 로고
    • Irritable bowel syndrome: new agents targeting serotonin receptor subtypes
    • F De Ponti M Tonini Irritable bowel syndrome: new agents targeting serotonin receptor subtypes Drugs 61 2001 317 332
    • (2001) Drugs , vol.61 , pp. 317-332
    • De Ponti, F1    Tonini, M2
  • 3
    • 85087998609 scopus 로고    scopus 로고
    • Alosetron in irritable bowel syndrome
    • KEL McColl Alosetron in irritable bowel syndrome Lancet 356 2000 164
    • (2000) Lancet , vol.356 , pp. 164
    • McColl, KEL1
  • 4
    • 85120115392 scopus 로고    scopus 로고
    • http://www.citizen.org/hrg/PUBLICATIONS/1566.htm (accessed on May 14, 2001)
  • 5
    • 85120140303 scopus 로고    scopus 로고
    • http://www.citizen.org/hrp/publications/fdasurvey.htm (accessed on May 14, 2001)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.